Trials / Completed
CompletedNCT03828188
Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level
A 12-week, Randomized, Double-blind, Placebo-controlled 2x2 Cross-over Design Human Trial to Evaluate the Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
This study was conducted to investigate the effects of daily supplementation of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level.
Detailed description
This study was a 12-week, randomized, double-blind, placebo-controlled 2x2 cross-over design human trial. 50 subjects which of 25 by group were randomly divided into Red Ginseng Concentrated Powder and a placebo group.(A total of 100 subjects completed the 2x2 cross-over study.)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Red Ginseng Concentrated Powder | Red Ginseng Concentrated Powder(4.9 g/day) for 12 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Placebo for 12 weeks. |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2018-05-11
- Completion
- 2019-05-08
- First posted
- 2019-02-04
- Last updated
- 2020-05-08
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03828188. Inclusion in this directory is not an endorsement.